Zurück
Tangui Maurice
Aufstrebend0Inserm
Kennzahlen
- h-Index
- —
- Zitationen
- —
- Publikationen
- —
Zusammensetzung
Erst-/Letztautor
0
Erfahrungs-Indikator aus Bibliometrie und der Evidenzstärke der eigenen Studien — kein Qualitätsurteil über die Person.
Studien bei MedPulse
- 2026-05-01Xanthatin-13-(Pyrrolidine-2-Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ25-35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease.
- 2026-04-13Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.
- 2026-04-05Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model.
- 2026-03-05Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse model.
- 2026-02-18A Dual Approach To Combat Alzheimer's Disease through Concomitant hBChE Inhibition and S1R Activation.